ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Internal Medicine

Top Internal Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
LUIS ANDUX M.D.

Internal Medicine

29,471

$931K

1083
964 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

1%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $56

CARLOS ROMERO M.D.

Internal Medicine

29,377

$1.47M

1217
878 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $56

KENNETH BERDICK M.D.

Internal Medicine

29,294

$1.55M

1245
606 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $56

LISA PATTANAYAK MD

Internal Medicine

29,218

$1.05M

1508
1197 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$36
Average prescription price

Avg: $56

MALATHI AKULA M.D.

Internal Medicine

29,018

$1.11M

1084
787 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $56

ZANDRA LOPEZ M.D.

Internal Medicine

28,622

$529K

2147
1915 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$18
Average prescription price

Avg: $56

SREELATHA TIRUPATHI M.D.

Internal Medicine

28,583

$1.2M

929
622 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

24%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $56

ELDA HERNANDEZ MD

Internal Medicine

28,339

$939K

687
654 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $56

LAWRENCE CAMPO M.D.

Internal Medicine

28,175

$1.04M

1241
993 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

1%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

FREDDY AVNI M.D.

Internal Medicine

28,144

$1.88M

1177
937 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$67
Average prescription price

Avg: $56

HIMANSHU PATEL MD

Internal Medicine

27,731

$1.08M

1017
754 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $56

LLOYD LAGRANGE M.D.

Internal Medicine

27,722

$1.3M

891
665 are 65+

20%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $56

FAUSTO DE LA CRUZ MD

Internal Medicine

27,556

$1.18M

933
822 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

BHUPENDRA PATEL M.D.

Internal Medicine

27,450

$1.3M

1368
1099 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $56

RADHIKA MENON M.D.

Internal Medicine

27,201

$1M

966
840 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$37
Average prescription price

Avg: $56

ROBERTO SOLER M.D.

Internal Medicine

27,128

$578K

1679
1452 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$21
Average prescription price

Avg: $56

HERNAN GOMEZ M.D.

Internal Medicine

27,043

$882K

1184
831 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$33
Average prescription price

Avg: $56

REINALDO CARVAJAL M.D.

Internal Medicine

26,961

$1.39M

577
524 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $56

PARIKSITH SINGH MD

Internal Medicine

26,953

$923K

2880
2320 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 8%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

YU HO WONG M.D.,

Internal Medicine

26,800

$899K

1095
896 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 25%

$34
Average prescription price

Avg: $56

IAN WEINSTEIN MD

Internal Medicine

26,786

$761K

1052
979 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 8%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$28
Average prescription price

Avg: $56

PHILIP ATIGRE MD

Internal Medicine

26,759

$1.48M

737
628 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $56

CLIFFORD BENEZRA MD

Internal Medicine

26,586

$1.13M

905
755 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $56

AIDA CASTRO M.D.

Internal Medicine

26,274

$1.42M

790
678 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $56

CRES RODRIGUEZ M.D.

Internal Medicine

26,201

$1.51M

847
697 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 8%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank